Xu F - Search Results

1

TLR3 activation enhances antitumor effects of sorafenib in hepatocellular carcinoma by activating NK cell functions through ERK and NF-κB pathways.

Zhang QB, Wang H, Xu F, Song Y, Jiang RD, Li Q, Liu EY. Zhang QB, et al. Among authors: xu f. Sci Rep. 2024 Nov 2;14(1):26422. doi: 10.1038/s41598-024-78316-3. Sci Rep. 2024. PMID: 39488569 Free PMC article.

2

LncRNA SOX21-AS1 is associated with progression of hepatocellular carcinoma and predicts prognosis through epigenetically silencing p21.

Wei C, Wang H, Xu F, Liu Z, Jiang R. Wei C, et al. Among authors: xu f. Biomed Pharmacother. 2018 Aug;104:137-144. doi: 10.1016/j.biopha.2018.05.010. Epub 2018 May 14. Biomed Pharmacother. 2018. PMID: 29772433

3

Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer.

Xu F, Cui WQ, Liu C, Feng F, Liu R, Zhang J, Sun CG. Xu F, et al. FEBS Open Bio. 2023 Jan;13(1):72-88. doi: 10.1002/2211-5463.13501. Epub 2022 Nov 28. FEBS Open Bio. 2023. PMID: 36282125 Free PMC article.

4

Combined treatment with cetuximab and STA9090 has synergistic anticancer effects on human non-small cell lung cancer.

Lu W, Liu L, Kang X, Ren K, Huang Y, Cheng M, Li X, Xu F, Xu X. Lu W, et al. Among authors: xu f, xu x. Acta Biochim Biophys Sin (Shanghai). 2024 May 30;56(7):1022-1033. doi: 10.3724/abbs.2024069. Acta Biochim Biophys Sin (Shanghai). 2024. PMID: 38818581 Free PMC article.

5

Non-immune cell components in tumor microenvironment influencing lung cancer Immunotherapy.

Zhang J, Liu S, Chen X, Xu X, Xu F. Zhang J, et al. Among authors: xu f, xu x. Biomed Pharmacother. 2023 Oct;166:115336. doi: 10.1016/j.biopha.2023.115336. Epub 2023 Aug 15. Biomed Pharmacother. 2023. PMID: 37591126 Free article. Review.

6

The role of macrophage polarization and cellular crosstalk in the pulmonary fibrotic microenvironment: a review.

Zhou BW, Liu HM, Xu F, Jia XH. Zhou BW, et al. Among authors: xu f. Cell Commun Signal. 2024 Mar 9;22(1):172. doi: 10.1186/s12964-024-01557-2. Cell Commun Signal. 2024. PMID: 38461312 Free PMC article. Review.

7

FHL1 as a novel prognostic biomarker and correlation with immune infiltration levels in lung adenocarcinoma.

Zhang J, Li H, Guo M, Zhang J, Zhang G, Sun N, Feng Y, Cui W, Xu F. Zhang J, et al. Among authors: xu f. Immunotherapy. 2023 Mar;15(4):235-252. doi: 10.2217/imt-2022-0195. Epub 2023 Jan 25. Immunotherapy. 2023. PMID: 36695131 Free article.

8

Systematic analysis and integrative discovery of active-site subpocket-specific dehydroquinate synthase inhibitors combating antibiotic-resistant Staphylococcus aureus infection.

Liu Q, Li L, Xu F. Liu Q, et al. Among authors: xu f. J Bioinform Comput Biol. 2018 Dec;16(6):1850027. doi: 10.1142/S0219720018500270. Epub 2018 Oct 30. J Bioinform Comput Biol. 2018. PMID: 30567475

9

Overexpression of SPP1 is a prognostic indicator of immune infiltration in lung adenocarcinoma.

Li B, Li X, Yang Q, Jiang Y, Zhang Q, Zhang J, Cui W, Xu F. Li B, et al. Among authors: xu f. Aging (Albany NY). 2024 Feb 7;16(3):2953-2977. doi: 10.18632/aging.205526. Epub 2024 Feb 7. Aging (Albany NY). 2024. PMID: 38329443 Free PMC article.

10

Ze-Qi decoction inhibits non-small cell lung cancer growth and metastasis by modulating the PI3K/Akt/p53 signaling pathway.

Zhang J, Zhuang Z, Guo M, Wu K, Yang Q, Min X, Cui W, Xu F. Zhang J, et al. Among authors: xu f. J Tradit Complement Med. 2023 Mar 20;13(5):417-429. doi: 10.1016/j.jtcme.2023.03.008. eCollection 2023 Sep. J Tradit Complement Med. 2023. PMID: 37693094 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,229 results

Search Page

Filters